2019 Dec
New England Journal of Medicine(NEJM / IF=70.670) 교신저자
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2018 Dec
CANCER LETTERS 공동저자
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
2018 Nov
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose
2018 Nov
ANNALS OF HEMATOLOGY 공동저자
Low frequency of CD3(+)CD4(+)CD161(+) T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment
2018 Oct
CANCER MEDICINE 교신저자
BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
2018 Oct
MEDICINE 공동저자
Cutaneous comorbidities in patients with multiple myeloma: A 10-year retrospective cohort study from a Korean population
2018 Oct
BONE MARROW TRANSPLANTATION 공동저자
Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia
2018 Oct
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia
2018 Sep
BLOOD CANCER JOURNAL 공동저자
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
2018 Aug
HAEMATOLOGICA 공동저자
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
2018 Aug
BLOOD 공동저자
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
2018 Aug
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome
2018 Aug
ANNALS OF HEMATOLOGY 교신저자
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
2018 Aug
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults
2018 Jul
BLOOD 공동저자
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
2018 Jun
INFECTION AND CHEMOTHERAPY 공동저자
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
2018 Jun
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
2018 May
CANCER MEDICINE 교신저자
Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia
2018 Apr
ANNALS OF INTERNAL MEDICINE 공동저자
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study
2018 Apr
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report
2018 Mar
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 공동저자
Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea
2018 Jan
ONCOTARGET 공동저자
Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy
2018 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation
2018 Jan
LEUKEMIA & LYMPHOMA 교신저자
Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy
2018 Jan
BIOMED RESEARCH INTERNATIONAL 공동저자
Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
2018 Jan
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
2017 Dec
Clinical Cancer Research 교신저자
Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia.
2017 Aug
Cancer 공동저자
Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
2017 Aug
대한면역학회 공동저자
Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
2017 Jul
Leukemia 교신저자
Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.
2017 Jun
Oncotarget 공동저자
Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.
2017 May
Clinica Chimica Acta 공동저자
Practical informativeness of short tandem repeat loci for chimerism analysis in hematopoietic stem cell transplantation.
2017 Apr
Biology of Blood and Marrow Transplantation 공동저자
Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
2017 Mar
PLoS One 공동저자
The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
2017 Feb
Transplant Infectious Disease 공동저자
Clinical significance of pre-transplant circulating CD3+ CD4+ CD161+ cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation.
2017 Feb
Oncotarget 공동저자
Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
2017 Jan
Journal of Hematology & Oncology 공동저자
High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
2017 Jan
Clinical Lymphoma Myeloma and Leukemia 공동저자
Characteristics and Survival Outcome Analysis of Extramedullary Involvement in Adult Patients With t(8;21) Acute Myeloid Leukemia.
2017 Jan
Korean journal of internal medicine 교신저자
BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan
대한내과학회 교신저자
BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan
Acta Derm Venereol 공동저자
Eruptive Melanocytic Naevi Caused by Radotinib Therapy in Patients with Chronic Myeloid Leukaemia: 10 cases and a literature Review.
2016 Dec
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
2016 Nov
BONE MARROW TRANSPLANTATION 공동저자
Comparable outcomes between younger (≤40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning
2016 Oct
BLOOD 공동저자
MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis
2016 Oct
BONE MARROW TRANSPLANTATION 공동저자
Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia
2016 Sep
LEUKEMIA 공동저자
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale
2016 Aug
CANCER IMMUNOLOGY IMMUNOTHERAPY 공동저자
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
2016 Aug
LEUKEMIA 공동저자
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
2016 Aug
LEUKEMIA & LYMPHOMA 교신저자
Optimization of radotinib doses for the treatment of Asian patients with chronic myelogenous leukemia based on dose-response relationship analyses
2016 Jul
LEUKEMIA 공동저자
Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
2016 Jun
ANNALS OF ONCOLOGY 공동저자
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
2016 Jun
HEPATOLOGY RESEARCH 공동저자
Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies
2016 Jun
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials
2016 Jun
HAEMATOLOGICA 교신저자
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: The KID study
2016 May
LEUKEMIA 공동저자
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
2016 Feb
BLOOD 공동저자
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
2016 Feb
CANCER SCIENCE 공동저자
Novel oral transforming growth factor- signaling inhibitor EW-7197 eradicates CML-initiating cells
2016 Feb
BRITISH JOURNAL OF DERMATOLOGY 공동저자
Acneiform eruptions caused by various second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
2016 Feb
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia
2016 Feb
LEUKEMIA & LYMPHOMA 교신저자
Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients
2016 Jan
BRITISH JOURNAL OF HAEMATOLOGY 공동저자
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
2015 Nov
THROMBOSIS RESEARCH 공동저자
Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients
2015 Oct
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
2015 Oct
CANCER RESEARCH AND TREATMENT 교신저자
Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
2015 Sep
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
2015 Aug
NATURE COMMUNICATIONS 공동저자
Dipeptide species regulate p38MAPK-Smad3 signalling to maintain chronic myelogenous leukaemia stem cells
2015 Aug
BONE MARROW TRANSPLANTATION 공동저자
Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation
2015 Aug
GENES CHROMOSOMES & CANCER 공동저자
Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations
2015 Apr
LEUKEMIA RESEARCH 교신저자
Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia
2015 Mar
HAEMATOLOGICA 교신저자
"Comment on ""Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors"""
2015 Mar
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
CD161(+) T Cells as Predictive Markers for Acute Graft-versus-Host Disease
2015 Mar
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation
2015 Mar
BONE MARROW TRANSPLANTATION 공동저자
Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL
2015 Mar
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Wilms Tumor Gene 1 Expression as a Predictive Marker for Relapse and Survival after Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes
2015 Feb
LEUKEMIA 공동저자
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR
2015 Jan
BLOOD 공동저자
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
2015 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
A well-tolerated regimen of 800cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmnipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia
2014 Dec
HEMATOLOGICAL ONCOLOGY 공동저자
Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence
2014 Nov
ACTA HAEMATOLOGICA 공동저자
Equivalent Outcome of Autologous Stem Cell Transplantation and Reduced Intensity Conditioning Stem Cell Transplantation in Acute Myeloid Leukemia Patients with t(8;21).
2014 Sep
LEUKEMIA & LYMPHOMA 교신저자
Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase
2014 Aug
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population
2014 Jul
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
2014 Jul
HAEMATOLOGICA 교신저자
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors
2014 Jul
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Similar outcomes of peripheral blood stem cells versus bone marrow for HLA-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft versus host disease prophylaxis
2014 Jun
BONE MARROW TRANSPLANTATION 공동저자
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL
2014 May
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study
2014 Apr
ANNALS OF HEMATOLOGY 공동저자
Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma
2014 Mar
HEMATOLOGY 교신저자
Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors
2014 Mar
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
2014 Feb
BRITISH JOURNAL OF HAEMATOLOGY 공동저자
Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma
2014 Feb
BLOOD 공동저자
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
2014 Jan
BLOOD 공동저자
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
2014 Jan
LEUKEMIA & LYMPHOMA 공동저자
Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia
2014 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Stratification of de novo Adult Acute Myelogenous Leukemia with Adverse-Risk Karyotype: Can We Overcome the Worse Prognosis of Adverse-Risk Group Acute Myelogenous Leukemia with Hematopoietic Stem Cell Transplantation?
2013 Dec
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status
2013 Dec
BONE MARROW TRANSPLANTATION 공동저자
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: Is it still reasonable to use t-PA?
2013 Nov
NEW ENGLAND JOURNAL OF MEDICINE 공동저자
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
2013 Oct
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 공동저자
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis
2013 Sep
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma
2013 Aug
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission
2013 Aug
BLOOD 공동저자
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
2013 Aug
LEUKEMIA 공동저자
Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells
2013 Aug
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: Consecutive monitoring in adult patients with core-binding-factor-positive AML
2013 Jun
LEUKEMIA 공동저자
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
2013 Jun
CLINICAL CHEMISTRY 공동저자
Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale
2013 Jun
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: Preliminary report of treatment outcomes after hematopoietic stem cell transplantation
2013 Jun
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Serial Measurement of WT1 Expression and Decrement Ratio Until Hematopoietic Cell Transplantation as a Marker of Residual Disease in Patients with Cytogenetically Normal Acute Myelogenous Leukemia
2013 Jun
ANNALS OF HEMATOLOGY 공동저자
The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study
2013 Jun
AMERICAN JOURNAL OF HEMATOLOGY 교신저자
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
2013 May
BONE MARROW TRANSPLANTATION 공동저자
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
2013 May
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission
2013 May
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia
2013 May
BLOOD 공동저자
Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase
2013 Apr
ANNALS OF HEMATOLOGY 공동저자
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum beta-lactamase production and its impact on outcome
2013 Apr
ANNALS OF HEMATOLOGY 공동저자
Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy
2013 Apr
BONE MARROW TRANSPLANTATION 공동저자
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
2013 Mar
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
2013 Feb
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes
2013 Feb
TRANSPLANT INFECTIOUS DISEASE 공동저자
Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens
2012 Nov
CANCER GENETICS 교신저자
The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate
2012 Nov
LEUKEMIA 공동저자
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
2012 Nov
ACTA HAEMATOLOGICA 공동저자
Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic anemia
2012 Oct
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
2012 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Comparison of Allogeneic Stem Cell Transplantation from Familial-Mismatched/Haploidentical Donors and from Unrelated Donors in Adults with High-Risk Acute Myelogenous Leukemia
2012 Oct
LEUKEMIA 공동저자
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
2012 Sep
JOURNAL OF MOLECULAR DIAGNOSTICS 공동저자
Genotyping of Chimerical BCR-ABL1 RNA in Chronic Myeloid Leukemia by Integrated DNA Chip
2012 Jul
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation
2012 Jul
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Graft-versus-Tumor Effect According to Type of Graft-versus-Host Disease Defined by National Institutes of Health Consensus Criteria and Associated Outcomes
2012 Jun
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 공동저자
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib
2012 May
BLOOD 공동저자
BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management
2012 Apr
LEUKEMIA RESEARCH 공동저자
Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia
2012 Apr
BLOOD 공동저자
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
2012 Apr
CYTOTHERAPY 공동저자
Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma
2012 Mar
ANNALS OF HEMATOLOGY 공동저자
Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation
2012 Feb
BLOOD 공동저자
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
2011 Dec
LEUKEMIA & LYMPHOMA 공동저자
Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and eff ective treatment option in elderly patients with acute myeloid leukemia
2011 Dec
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Survival benefits from reduced-intensity conditioning in allogeneic stem cell transplantation for young lower-risk MDS patients without significant comorbidities
2011 Oct
BLOOD 공동저자
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive CML patients with resistance or intolerance to imatinib
2011 Oct
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy
2011 Sep
KOREAN JOURNAL OF HEMATOLOGY(대한혈액학회지/2012년 까지 게재) 단독
Recent advances in the path toward the cure for chronic myeloid leukemia
2011 Jun
ACTA HAEMATOLOGICA 공동저자
Reduced-Intensity Conditioning Regimen Combined with Low-Dose Total Body Irradiation in the Treatment of Myelodysplastic Syndrome
2011 May
LEUKEMIA & LYMPHOMA 교신저자
Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay
2011 Apr
JOURNAL OF THE NATIONAL CANCER INSTITUTE 공동저자
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
2011 Feb
LEUKEMIA 공동저자
The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response
2011 Feb
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 제1/교신저자
Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
2011 Jan
BLOOD 공동저자
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results
2011 Jan
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Bone scan images reveal increased osteoblastic function after bortezomib treatment in patients with multiple myeloma
2010 Dec
LEUKEMIA 공동저자
Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia
2010 Dec
INTERNATIONAL JOURNAL OF DERMATOLOGY 공동저자
Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases:a retrospective study in Korean patients
2010 Nov
BLOOD 공동저자
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
2010 Nov
LEUKEMIA RESEARCH 교신저자
Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era
2010 Oct
TRANSPLANTATION 공동저자
Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation
2010 Sep
GENES CHROMOSOMES & CANCER 공동저자
The Characteristics and Clinical Outcome of Adult Patients with Aplastic Anemia and Abnormal Cytogenetics at Diagnosis
2010 Sep
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities
2010 Aug
BONE MARROW TRANSPLANTATION 공동저자
Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center
2010 Aug
NATURE 공동저자
Regulation of myeloid leukaemia by the cell-fate determinant Musashi
2010 Jul
LEUKEMIA 공동저자
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
2010 Jun
INFECTION AND CHEMOTHERAPY (구.감염과 화학요법) 공동저자
조혈모세포이식 환자에서 침습성 진균 감염에 대한 Micafungin의 예방 효과 및 안전성
2010 Jun
BMC CELL BIOLOGY 공동저자
Transdifferentiation-inducing HCCR-1 oncogene
2010 Jun
HEMATOLOGICAL ONCOLOGY 교신저자
Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors
2010 Jun
NEW ENGLAND JOURNAL OF MEDICINE 공동저자
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
2010 May
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
High Levels of B Cell Activating Factor During the Peritransplantation Period Are Associated with a Reduced Incidence of Acute Graft-versus-Host Disease following Myeloablative Allogeneic Stem Cell Transplantation
2010 Mar
BONE MARROW TRANSPLANTATION 공동저자
Potential role of adoptively transferred allogeneic WT1-specific CD4(+) and CD8(+) T lymphocytes for the sustained remission of refractory AML
2010 Feb
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 공동저자
Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response or intolerance to imatinib
2010 Jan
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study
2009 Dec
BLOOD 공동저자
Epidemiologic study on survival of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia patients with BCR-ABL T315I mutation
2009 Dec
KOREAN JOURNAL OF HEMATOLOGY(대한혈액학회지/2012년 까지 게재) 공동저자
Oral beclomethasone dipropionate for the treatment of steroid-refractory gastrointestinal acute graft-versus-host disease
2009 Dec
BLOOD 공동저자
Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
2009 Dec
HEMATOLOGICAL ONCOLOGY 교신저자
Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent
2009 Oct
LEUKEMIA 공동저자
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study
2009 Sep
LEUKEMIA 공동저자
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value
2009 Sep
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase
2009 Sep
LEUKEMIA RESEARCH 교신저자
Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations
2009 Aug
TRANSPLANTATION 공동저자
Full Donor Chimerism Using Stem Cell Transplantation for Tolerencee induction in the Human Leukocyte Antigen-matched liver transplant setting.
2009 Jul
BLOOD 공동저자
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
2009 Jul
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
2009 Jun
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia
2009 Jun
LEUKEMIA & LYMPHOMA 교신저자
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy
2009 Apr
CANCER 공동저자
Dasatinib Treatment for Philadelphia Chromosome-positive Leukemias
2009 Feb
INFECTION AND CHEMOTHERAPY (구.감염과 화학요법) 공동저자
조혈모세포이식 환자에서 발생한 Cytomegalovirus 질환의 특징 : 일개 대학병원에서 최근 10년간의 경험
2009 Jan
LEUKEMIA 공동저자
Feasibility of NIH consensus criteria for chronic graft-versus-host disease
2009 Jan
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Chronic myeloid leukemia in Asia
2008 Dec
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 공동저자
Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia
2008 Dec
LEUKEMIA 공동저자
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
2008 Jul
PLOS ONE 공동저자
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML)
2008 Jul
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
2008 May
JOURNAL OF BIOLOGICAL CHEMISTRY 공동저자
Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATM
2008 May
BONE MARROW TRANSPLANTATION 공동저자
Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
2008 Mar
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.
2008 Feb
BLOOD 공동저자
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
2007 Dec
대한위암학회지 공동저자
혈액질환에 속발하는 이차성 위암
2007 Dec
KOREAN JOURNAL OF HEMATOLOGY(대한혈액학회지/2012년 까지 게재) 공동저자
고용량 스테로이드에도 반응이 없는 스테로이드저항성 이식편대숙주질환에 대한 체외광분반술의 효과
2007 Dec
BONE MARROW TRANSPLANTATION 공동저자
Anti-leukaemic Role of Acute GvHD after Unrelated Haematopoietic Stem Cell Transplantation in Intermediate- to High-risk Acute Myelogenous Leukaemia
2007 Nov
TRANSPLANTATION 공동저자
The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia
2007 Nov
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older
2007 Oct
BONE MARROW TRANSPLANTATION 공동저자
Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT
2007 Sep
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: Antileukemic activity of chronic graft-versus-host disease
2007 Jul
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide
2007 Jun
KOREAN JOURNAL OF HEMATOLOGY(대한혈액학회지/2012년 까지 게재) 공동저자
Viruria in adult hemorrhagic cystitis patients following allogeneic hematopoietic stem cell transplantation and implication of antiviral treatment
2007 Jun
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 교신저자
Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines
2007 Jun
KOREAN JOURNAL OF HEMATOLOGY(대한혈액학회지/2012년 까지 게재) 공동저자
Hematopoietic Stem Cell Transplantation with using Multinational Unrelated Donors for Acute Myelogenous Leukemia
2007 Jun
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine-busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome
2007 May
BLOOD 공동저자
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
2007 Apr
BLOOD 공동저자
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis
2007 Apr
TISSUE ANTIGENS 공동저자
Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
2007 Mar
KOREAN JOURNAL OF HEMATOLOGY(대한혈액학회지/2012년 까지 게재) 공동저자
Susceptibility of Leukemia according to the Genotype of Minor Histocompatibility Antigens in a Korean Population.
